ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGL Angle Plc

8.00
0.00 (0.00%)
09 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.00 7.50 8.50 8.00 8.00 8.00 1,015,704 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 2.19M -20.13M -0.0624 -1.28 25.81M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 8p. Over the last year, Angle shares have traded in a share price range of 7.25p to 37.50p.

Angle currently has 322,641,668 shares in issue. The market capitalisation of Angle is £25.81 million. Angle has a price to earnings ratio (PE ratio) of -1.28.

Angle Share Discussion Threads

Showing 34751 to 34770 of 34775 messages
Chat Pages: 1391  1390  1389  1388  1387  1386  1385  1384  1383  1382  1381  1380  Older
DateSubjectAuthorDiscuss
09/10/2024
19:01
CTCs only of use in research not clinical trials was the message I came away with.
toffeeman
09/10/2024
16:11
Lots of rollovers today to fool mislead any novice that there strong buying or weak selling when it's around mid price to sell currently online
dave4545
09/10/2024
14:52
How ctDNA Can Unveil Early Signs of Molecular Response in Drug Development
Wednesday, October 09, 2024 18.00

hxxps://event.on24.com/eventRegistration/EventLobbyServlet?target=lobby30.jsp&eventid=4679241&sessionid=1&partnerref=site&format=fhvideo1&key=ADABC1F6BCF6D186DACDCCC776E31D74&eventuserid=703528833

toffeeman
09/10/2024
13:07
Castor you referring to Bliss Bio and their partnering with Eisai?
Agl's parsortix was adopted for patient selection?

I remember in the Jan rns they referred to BB1701

"ANGLE plc...is delighted to announce that it has signed a contract with the global pharmaceutical company, Eisai Inc...Under the agreement, in a pilot study worth US $250,000 to ANGLE, ANGLE will provide CTC analysis with its Portrait HER2 assay to assess breast cancer patients' HER2 (human epidermal growth factor receptor 2) status in a Phase II study of the HER2 targeting antibody-drug conjugate (ADC) BB-1701. Success in the pilot study offers the potential for multiple large scale follow-up studies....ANGLE's Portrait HER2 assay enables quantitative assessment of both HER2 protein expression (via IF) and HER2/neu gene amplification (via FISH) to identify patients who could benefit from anti-HER2 ADC treatment."

boris cobaka
09/10/2024
12:40
Looking online the spread is quite good.

It's around 0.35p inside both ways so 7.85-8.15p approx the spread

The mm's seem to be happy with all this 2 way trade each day, no need to move the price and they are making a daily crust while concentrating on other fast moving stocks.

Agl will have it's day or spike but it's a case of when and from what level.

dave4545
09/10/2024
12:22
Paulx she confirmed it earlier. Are you only on lse?
At Least 300k taken on the strength but I'm not sure.
Ignorance is Bliss I guess.

castor111
09/10/2024
09:49
Thanks for that...although I was thinking more of a couple of big fat cheques to get the ball rolling as it were....:-))
sawney
09/10/2024
09:33
sawney

...........that link is to Angle presenting their DDR assay which was commissioned and paid for by Artios Pharma and led to contract with AstraZeneca.

bermudashorts
09/10/2024
09:18
Victor Meldrew Vs Adrian Mole are fighting it out on an anonymous bulletin board.Are you not entertained?
atmysignal
09/10/2024
09:14
Thanks Sawney.Let's leave adwbones to their multiple aliases. Childish.Great prospects here.
muffster
09/10/2024
09:09
...and another...pity big pharma has still not got the cheque book out...
sawney
09/10/2024
08:38
You’re not anywhere near as clever as you think. It’s why you can’t address what I’m actually saying, instead once again bragging how you made money. You had a go at me on 29th May for saying I thought a placing was coming and by 7th June when it came you claimed you’d sold down because you knew it was.

Nowhere have I said I think these boards affect the price. I’ve said you do. You’ve been caught out but yes let’s leave it there and you filter me pal - better than when you were sending me private messages when you agreed with my analysis, whereas when I called you out you suddenly hate me.

I’ll be keeping my eye on you and your narcissistic rat like behaviour though.

adw198
09/10/2024
08:03
Nah, Adw is Victor Meldrew
atmysignal
08/10/2024
22:34
698 and adw....same person I reckons.
muffster
08/10/2024
17:18
I watch the blood for signals bright,Not tissue's tale, but fluid's light.I track the HER2, high or low,A patient's path, I aim to show.Pharma eyes are on my test,For outcomes better than the rest.What am I, with change in sight,Disrupting norms in silent flight?:)
5oletrader
08/10/2024
08:25
Calm down dear!Bones is an anonymous poster on a bulletin board
atmysignal
08/10/2024
02:29
Oh dear that clearly touched a nerve and yes I have read your posts on this and many other boards.

But at least you are now being more open and honest which is ok.

Please don't worry too much about my losses on this or any other share, as I have a very wide portfolio and have been investing (note the difference) on a number of shares for a very long time and I am fully aware of the risks of further potential fundraises but I don't disguise the fact that I am not currently invested in AGL please see my post 25097 before the latest raise.

ATB

pj84
07/10/2024
22:46
I am a strong believer in the science and that Angle will eventually see the promise that I, like a lot of shareholders at the time, believed initially would quickly follow from the FDA approval and lead to deals and commercialisation. At that stage I was worried we would get bought out too quickly by the likes of Abbot. We all now know that was wrong.

Since then, like a lot of holders I have realised that commercialisation is further ahead than we believed at the time, and I have been sitting on the sidelines waiting for the right time to reinvest.

Unlike Bones I like to think my posts are more balanced and my last post 26242 posted a positive update by Berenberg with a price target of 70p but my own comments at the end were “If it's similar to this year the full year results for December 24 will be released in early June 25.

At this stage I still have doubts about whether the cash in June 25 will be sufficient to see them through to H2 26 but that may change depending on what happens between now and June 25.”

My position hasn’t changed since then.

Bones on the other hand has had a complete 180 change of view from there will definitely be a need for another fundraise around the time of the full year 24 results, to I have now bought and don’t see that as a problem anymore (but he no doubt reserves the right to sell at any point between now and then and will again post with certainty that there will be a fundraise!)

pj84
07/10/2024
13:47
Can triple or more. Look at it's history.Ask Bones LOL
atmysignal
07/10/2024
13:44
And the rest Dave, and the rest.
jelenko
Chat Pages: 1391  1390  1389  1388  1387  1386  1385  1384  1383  1382  1381  1380  Older

Your Recent History

Delayed Upgrade Clock